Koninklijke Philips Operating Income 2010-2024 | PHG
Koninklijke Philips annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Koninklijke Philips operating income for the quarter ending September 30, 2024 was $0.372B, a 3074.72% increase year-over-year.
- Koninklijke Philips operating income for the twelve months ending September 30, 2024 was $0.867B, a 14.26% increase year-over-year.
- Koninklijke Philips annual operating income for 2023 was $-0.124B, a 92.27% decline from 2022.
- Koninklijke Philips annual operating income for 2022 was $-1.61B, a 346.07% decline from 2021.
- Koninklijke Philips annual operating income for 2021 was $0.654B, a 62.86% decline from 2020.
| Koninklijke Philips Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-124 |
| 2022 | $-1,610 |
| 2021 | $654 |
| 2020 | $1,761 |
| 2019 | $1,842 |
| 2018 | $2,029 |
| 2017 | $1,715 |
| 2016 | $2,083 |
| 2015 | $1,102 |
| 2014 | $646 |
| 2013 | $2,645 |
| 2012 | $1,325 |
| 2011 | $1,443 |
| 2010 | $2,641 |
| 2009 | $774 |
| Koninklijke Philips Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $372 |
| 2024-06-30 | $879 |
| 2023-06-30 | $242 |
| 2023-03-31 | $-626 |
| 2022-06-30 | $12 |
| 2021-06-30 | $102 |
| 2020-06-30 | $252 |
| 2019-06-30 | $392 |
| 2018-06-30 | $355 |
| 2017-06-30 | $278 |
| 2016-12-31 | $902 |
| 2016-09-30 | $537 |
| 2016-06-30 | $425 |
| 2016-03-31 | $220 |
| 2015-12-31 | $178 |
| 2015-09-30 | $381 |
| 2015-06-30 | $386 |
| 2015-03-31 | $157 |
| 2014-12-31 | $2 |
| 2014-09-30 | $-121 |
| 2014-06-30 | $455 |
| 2014-03-31 | $310 |
| 2013-12-31 | $962 |
| 2013-09-30 | $615 |
| 2013-06-30 | $665 |
| 2013-03-31 | $403 |
| 2012-12-31 | $95 |
| 2012-09-30 | $745 |
| 2012-06-30 | $206 |
| 2012-03-31 | $586 |
| 2011-12-31 | $-38 |
| 2011-09-30 | $200 |
| 2011-06-30 | $334 |
| 2011-03-31 | $831 |
| 2010-12-31 | $986 |
| 2010-09-30 | $632 |
| 2010-06-30 | $516 |
| 2010-03-31 | $525 |
| 2009-12-31 | $2,266 |
| 2009-09-30 | $407 |
| 2009-06-30 | $-1,070 |
| 2009-03-31 | $-254 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.692B | $19.663B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.284B | 25.22 |
| Stryker (SYK) | United States | $148.861B | 33.55 |
| Boston Scientific (BSX) | United States | $147.840B | 42.50 |
| EssilorLuxottica (ESLOY) | France | $120.398B | 0.00 |
| Medtronic (MDT) | Ireland | $112.636B | 16.73 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.153B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.736B | 27.12 |
| GE HealthCare Technologies (GEHC) | United States | $39.899B | 20.69 |
| ResMed (RMD) | United States | $36.307B | 29.83 |
| Terumo (TRUMY) | Japan | $28.860B | 40.76 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.842B | 13.91 |
| Insulet (PODD) | United States | $19.563B | 77.90 |
| Baxter (BAX) | United States | $16.252B | 10.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.094B | 34.30 |
| BellRing Brands (BRBR) | United States | $9.817B | 39.50 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.632B | 15.41 |
| ICU Medical (ICUI) | United States | $4.089B | 38.93 |
| Prestige Consumer Healthcare (PBH) | United States | $3.823B | 19.01 |
| Haemonetics (HAE) | United States | $3.684B | 17.98 |
| Envista Holdings (NVST) | United States | $3.623B | 26.99 |
| Perrigo (PRGO) | Ireland | $3.281B | 9.66 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.992B | 19.25 |
| GN Store Nord (GNNDY) | Denmark | $2.797B | 17.94 |
| Neogen (NEOG) | United States | $2.592B | 29.88 |
| LeMaitre Vascular (LMAT) | United States | $2.203B | 53.55 |
| AtriCure (ATRC) | United States | $1.926B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.514B | 26.50 |
| InMode (INMD) | Israel | $1.434B | 8.62 |
| AdaptHealth (AHCO) | United States | $1.368B | 9.78 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.343B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.274B | 0.00 |
| Owens & Minor (OMI) | United States | $1.145B | 8.95 |
| Curaleaf Holdings (CURLF) | Canada | $0.903B | 0.00 |
| Evolus (EOLS) | United States | $0.895B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.881B | 15.54 |
| CeriBell (CBLL) | United States | $0.833B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.678B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.572B | 25.24 |
| Omeros (OMER) | United States | $0.538B | 0.00 |
| Surmodics (SRDX) | United States | $0.530B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.418B | 0.00 |
| ZimVie (ZIMV) | United States | $0.391B | 32.91 |
| Quanterix (QTRX) | United States | $0.386B | 0.00 |
| Valneva SE (VALN) | France | $0.376B | 0.00 |
| Cerus (CERS) | United States | $0.336B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.330B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Biote (BTMD) | United States | $0.307B | 6.73 |
| OraSure Technologies (OSUR) | United States | $0.290B | 19.45 |
| Canopy Growth (CGC) | Canada | $0.263B | 0.00 |
| Zynex (ZYXI) | United States | $0.261B | 54.53 |
| High Tide (HITI) | Canada | $0.244B | 100.33 |
| Sanuwave Health (SNWV) | United States | $0.233B | 3.28 |
| Utah Medical Products (UTMD) | United States | $0.213B | 14.71 |
| Aurora Cannabis (ACB) | Canada | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 110.50 |
| Organigram Holdings (OGI) | Canada | $0.198B | 0.00 |
| MacroGenics (MGNX) | United States | $0.193B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.153B | 0.00 |
| Veru (VERU) | United States | $0.152B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.29 |
| Jin Medical (ZJYL) | China | $0.136B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 11.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| InterCure (INCR) | Israel | $0.078B | 0.00 |
| INLIF (INLF) | $0.074B | 0.00 | |
| Exagen (XGN) | United States | $0.071B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.070B | 36.33 |
| Apyx Medical (APYX) | United States | $0.057B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.07 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |